Lazard Asset Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
WHG
SAM
Lazard Asset Management's CNMD Position: Q3 2025 in Review
Lazard Asset Management sold out of CONMED (CNMD) in Q3 2025, closing a stake of 621 shares — an estimated $32K sold.
Lazard Asset Management first reported a position in CNMD in Q2 2019 and held it in 21 quarters. The position peaked at $8.05M in Q4 2021. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.
- Lazard Asset Management reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
- Lazard Asset Management sold 621 CONMED shares in Q3 2025, an estimated $32K.
- Lazard Asset Management first reported a position in CONMED in Q2 2019 and held it in 21 quarters.
- Lazard Asset Management's CONMED position peaked at $8.05M in Q4 2021.
- 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.
Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.